Trial intelligence / Profile preview

Comparison of Tamsulosin and Silodosin on Anatomical Iris Changes in BPH Patients

NCT07743034Phase 4Not yet recruiting

Start
Aug 2026
Primary completion
Apr 2027
01

Overview

A Phase 4 trial of tamsulosin, silodosin in benign prostatic hyperplasia (BPH). Planned start Aug 2026; status: not yet recruiting.

02

Drugs

tamsulosinsilodosin
03

Conditions

benign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on NCT07743034.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07743034.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call